Abstract Details
|
Mohamed Kazamel, MD
(UAB)
PRESENTER |
Dr. Kazamel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam Pharamceuticals. Dr. Kazamel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea Therapeutics. |
| Khurram Bashir, MD (Univ Alabama Birmingham Dept of Neuro) | The institution of Dr. Bashir has received research support from NIH. The institution of Dr. Bashir has received research support from PICORI. The institution of Dr. Bashir has received research support from Sanofi. Dr. Bashir has received research support from GWSP. The institution of Dr. Bashir has received research support from Roche. The institution of Dr. Bashir has received research support from Novartis. The institution of Dr. Bashir has received research support from Hoffmann-La Roche. |
| Shin J. Oh, MD, FAAN | No disclosure on file |
| No disclosure on file | |
| Mohammad Alsharabati, MD (Advocate Medical Group) | No disclosure on file |